NMR-based screening of protein inhibitors in drug discovery
Hu, H-yu.
Yao Xue Xue Bao 37(2): 158-160
2002
ISSN/ISBN: 0513-4870 PMID: 12579966 Document Number: 546742
Document emailed within 1 workday
Related Documents
Zartler, E.R.; Shapiro, M.J. 2006: Protein NMR-based screening in drug discovery Current Pharmaceutical Design 12(31): 3963-3972Chang, G.; Ruggeri, R.B.; Harwood, H.James. 2002: Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms Current Opinion in Drug Discovery and Development 5(4): 562-570
Reid, T-Elinor.; Fortunak, J.M.; Wutoh, A.; Simon Wang, X. 2016: Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors Current Topics in Medicinal Chemistry 16(13): 1452-1462
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Aarthy, M.; Singh, S.Kumar. 2018: Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach Current Topics in Medicinal Chemistry 18(18): 1585-1602
Xu, H. 2002: Retrospect and prospect of virtual screening in drug discovery Current Topics in Medicinal Chemistry 2(12): 1305-1320
Muchmore, S.W.; Hajduk, P.J. 2003: Crystallography, NMR and virtual screening: integrated tools for drug discovery Current Opinion in Drug Discovery and Development 6(4): 544-549
Boehm, H.J.; Boehringer, M.; Bur, D.; Gmuender, H.; Huber, W.; Klaus, W.; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Meunier-Keller, N.; Mueller, F. 2000: Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening Journal of Medicinal Chemistry 43(14): 2664-2674
Jacoby, E.; Davies, J.; Blommers, M.J.J. 2003: Design of small molecule libraries for NMR screening and other applications in drug discovery Current Topics in Medicinal Chemistry 3(1): 11-23
Golz, S.; Jörg Hüser 2007: Discovery of a New Drug - From Target Identification to Ultra-High-Throughput Screening Clinical Laboratory 53(1-2): 77-79
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Kochendoerfer, G.G. 2001: Chemical protein synthesis methods in drug discovery Current Opinion in Drug Discovery and Development 4(2): 205-214
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Langer, T.; Krovat, E.Maria. 2003: Chemical feature-based pharmacophores and virtual library screening for discovery of new leads Current Opinion in Drug Discovery and Development 6(3): 370-376
Ren, J.; Li, J.; Shi, F.; Wang, X.; He, J-Hua.; Xu, Y-Chun.; Zhang, N-Xia.; Xiong, B.; Shen, J-Kang. 2013: Progress in the fragment-based drug discovery Yao Xue Xue Bao 48(1): 14-24
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Hu, L-hong.; Xu, J-qing. 2009: Drug discovery based on classic natural products Yao Xue Xue Bao 44(1): 11-18
Pirhadi, S.; Shiri, F.; Ghasemi, J.B. 2013: Methods and applications of structure based pharmacophores in drug discovery Current Topics in Medicinal Chemistry 13(9): 1036-1047
Xu, J. 2004: Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. Dipeptidyl peptidase-IV inhibitors 26-27 July 2004, San Diego, CA, USA IDrugs: the investigational drugs journal 7(9): 839-840
O'Hanlon, K. 1999: Applied proteomics--analyzing protein structure and function for drug discovery. 27-28 January 1999, London, UK IDrugs: the investigational drugs journal 2(4): 299-300